1.
2.
3.
4.
As US measles cases rise, biotech firms start developing new treatments
(arstechnica.com)
6.
Argenx to Buy Forte Biosciences for $2.2 Billion
(feeds.content.dowjones.io)
7.
The Scientist With 1,000 Patents Fueling a Drug Powerhouse
(feeds.content.dowjones.io)
8.
The Download: an organ transplant breakthrough, and homegrown Chinese chips
(technologyreview.com)
9.
AI-redesigned starting points and outcomes enhance protein evolution
(feeds.nature.com)
11.
12.
CVS is now filling prescriptions for dogs and cats. Here’s what pet owners need to know
(feeds.feedburner.com)
13.
DNA-shredding CRISPR enzyme takes aim at cancer cells
(feeds.nature.com)
14.
U.S. Biotechs Are Keeping More Secrets to Beat Copycats in China
(feeds.content.dowjones.io)
15.
Lego’s July Releases Are Few But Mighty
(gizmodo.com)
16.
Novartis to Buy Myricx Bio for Up to $1.5 Billion
(feeds.content.dowjones.io)
17.
Anthropic wants to develop its own drugs
(theverge.com)
18.
Abivax Shares Continue Climbing After Biotech Firm Moves to Bolster Balance Sheet
(feeds.content.dowjones.io)
19.
20.
21.
Ipsen to Buy Swiss Biotech Memo in Deal That Could Top $800 Million
(feeds.content.dowjones.io)
23.
How Seriously Should We Take The Threat of Mirror Life?
(gizmodo.com)
24.
25.
Germany’s Merck to Boost Lab-Tools Business With $11 Billion Bio-Techne Deal
(feeds.content.dowjones.io)
26.
28.
Ending respiratory infections
(news.ycombinator.com)
29.
Ending All Respiratory Infections
(news.ycombinator.com)
30.
Antibiotic cocktail made by soil bacteria can kill superbugs
(feeds.nature.com)